Back
Outlook Therapeutics Stock Predictions
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
25
OTLK
Outlook Therapeutics
Last Price:
5.76
Seasonality Move:
-12.63%
7 Day Trial
ALL ACCESS PASS
$
7
"If I Had To Start Again..." Expert Reveals #1 Investing Hack
In his latest free guide, Duffy reveals... click here to continue reading...Outlook Therapeutics Stock Forecast
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 24.2% based on the past 8 years of stock performance.
- Outlook Therapeutics has fallen lower in 7 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%
-
Is Outlook Therapeutics Stock Undervalued?
The current Outlook Therapeutics [OTLK] share price is $5.75. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. - OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Outlook Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 24.2% based on the past 8 years of stock performance.
Outlook Therapeutics Stock Rating
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics overpriced?
- Outlook Therapeutics has fallen lower in 7 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%
Outlook Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
outlooktherapeutics.com
52-Week Data
52-Week High:
12.85
52-Week Low:
4.61
Prediction Charts
Market Cap:
136.02M
Price in USD:
5.75
Volume:
136.24K
Beta:
0.36
Technical Analysis
SMA50:
6.11
SMA100:
6.90
SMA200:
7.54
52-Wk Change:
-52.08%
Stock Predictions
-
Is Outlook Therapeutics stock public?
Yes, Outlook Therapeutics is a publicly traded company. -
What is the Outlook Therapeutics stock quote today?
The Outlook Therapeutics stock price is 5.75 USD today. -
How to buy Outlook Therapeutics stock online?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-11 | 4.94 | 5.15 | 5.24 | 4.94 |
| Oct-14 | 5.13 | 5.09 | 5.27 | 5.03 |
| Oct-15 | 5.06 | 5.12 | 5.27 | 4.95 |
| Oct-16 | 5.17 | 5.19 | 5.27 | 5.10 |
| Oct-18 | 5.17 | 5.31 | 5.34 | 4.96 |
| Oct-21 | 5.42 | 5.69 | 5.75 | 5.38 |
| Oct-22 | 5.68 | 5.54 | 5.78 | 5.49 |
| Oct-23 | 5.52 | 5.27 | 5.58 | 4.92 |
| Oct-24 | 5.33 | 5.35 | 5.40 | 5.15 |
| Oct-25 | 5.38 | 5.44 | 5.59 | 5.30 |
| Oct-28 | 5.55 | 5.76 | 5.84 | 5.51 |
| Oct-29 | 5.80 | 5.73 | 5.94 | 5.68 |
| Oct-30 | 5.71 | 5.77 | 5.86 | 5.66 |
| Oct-31 | 5.82 | 5.75 | 5.85 | 5.68 |
Outlook Therapeutics Earnings
Outlook Therapeutics Earnings Report: Per Share Outlook Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Outlook Therapeutics Forecast Revenue Growth
Outlook Therapeutics Stock Analysis: Historical quarterly revenues per share for Outlook Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.